New Insights into Human Cytomegalovirus pUL52 Structure
Human cytomegalovirus (HCMV) can cause serious diseases in immunocompromised patients. Current antiviral inhibitors all target the viral DNA polymerase. They have adverse effects, and prolonged treatment can select for drug resistance mutations. Thus, new drugs targeting other stages of replication...
Main Authors: | Clotilde Muller, Sophie Alain, Claire Gourin, Thomas F. Baumert, Gaëtan Ligat, Sébastien Hantz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/13/8/1638 |
Similar Items
-
Cytomégalovirus humain, mutations de résistance et nouvelles cibles thérapeutiques
by: Ligat, Gaëtan
Published: (2017) -
Functional Relevance of the Interaction between Human Cyclins and the Cytomegalovirus-Encoded CDK-Like Protein Kinase pUL97
by: Martin Schütz, et al.
Published: (2021-06-01) -
Hinge Region in DNA Packaging Terminase pUL15 of Herpes Simplex Virus: A Potential Allosteric Target for Antiviral Drugs
by: Lana F. Thaljeh, et al.
Published: (2019-10-01) -
Characterization of the Transcripts that Encode pUL138, a Latency Determinant, During Human Cytomegalovirus Infection
by: Grainger, Lora Ann
Published: (2010) -
Changes in subcellular localization reveal interactions between human cytomegalovirus terminase subunits
by: Wang Jian Ben, et al.
Published: (2012-12-01)